Caenorhabditis elegans as a model system for human diseases

被引:72
|
作者
Markaki, Maria [1 ]
Tavernarakis, Nektarios [1 ,2 ]
机构
[1] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece
[2] Univ Crete, Sch Med, Dept Basic Sci, Iraklion 70013, Crete, Greece
基金
欧洲研究理事会;
关键词
ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; CELL-DEATH; C-ELEGANS; TAU; AGGREGATION; GENETICS; SUSCEPTIBILITY; NEUROTOXICITY;
D O I
10.1016/j.copbio.2019.12.011
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The nematode Caenorhabditis elegans offers unique advantages that enable a comprehensive delineation of the cellular and molecular mechanisms underlying devastating human pathologies such as stroke, ischemia and age-associated neurodegenerative disorders. Genetic models of human diseases that closely simulate several disease-related phenotypes have been established in the worm. These models allow the implementation of multidisciplinary approaches, in addition to large-scale genetic and pharmacological screenings, designed to elucidate the molecular mechanisms mediating pathogenesis and to identify targets and drugs for emergent therapeutic interventions. Such strategies have already provided valuable insights, highly relevant to human health and quality of life. This article considers the potential of C. elegans as a versatile platform for systematic dissection of the molecular basis of human disease, focusing on neurodegenerative disorders.
引用
收藏
页码:118 / 125
页数:8
相关论文
共 50 条
  • [11] The worm in us -: Caenorhabditis elegans as a model of human disease
    Baumeister, R
    Ge, LM
    TRENDS IN BIOTECHNOLOGY, 2002, 20 (04) : 147 - 148
  • [12] Model System Caenorhabditis elegans and Neurodegenerative Disease Research
    Nazir, Aamir
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (08) : 955 - 956
  • [13] Caenorhabditis elegans as a model system for mtDNA replication defects
    Bratic, Ivana
    Hench, Jurgen
    Trifunovic, Aleksandra
    METHODS, 2010, 51 (04) : 437 - 443
  • [14] Caenorhabditis elegans as a model system for Parkinson's disease
    Schmidt, Enrico
    Seifert, Mark
    Baumeister, Ralf
    NEURODEGENERATIVE DISEASES, 2007, 4 (2-3) : 199 - 217
  • [15] Modeling neurodegenerative diseases in Caenorhabditis elegans
    Li, Jia
    Le, Weidong
    EXPERIMENTAL NEUROLOGY, 2013, 250 : 94 - 103
  • [16] Caenorhabditis elegans as a Model System for Duchenne Muscular Dystrophy
    Ellwood, Rebecca A.
    Piasecki, Mathew
    Szewczyk, Nathaniel J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [17] Antioxidant capacity of sesamol in Caenorhabditis elegans model system
    Jinian Huang
    Shuning Qi
    Qiang Sun
    Guohui Song
    Jixing Tang
    Yuquan Duan
    Food Production, Processing and Nutrition, 6
  • [18] Caenorhabditis elegans as a model system to study post-translational modifications of human transthyretin
    Henze, Andrea
    Homann, Thomas
    Rohn, Isabelle
    Aschner, Michael
    Link, Christopher D.
    Kleuser, Burkhard
    Schweigert, Florian J.
    Schwerdtle, Tanja
    Bornhorst, Julia
    SCIENTIFIC REPORTS, 2016, 6
  • [19] Caenorhabditis elegans as an emerging model system in environmental epigenetics
    Weinhouse, Caren
    Truong, Lisa
    Meyer, Joel N.
    Allard, Patrick
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2018, 59 (07) : 560 - 575
  • [20] Antioxidant capacity of sesamol in Caenorhabditis elegans model system
    Huang, Jinian
    Qi, Shuning
    Sun, Qiang
    Song, Guohui
    Tang, Jixing
    Duan, Yuquan
    FOOD PRODUCTION PROCESSING AND NUTRITION, 2024, 6 (01)